As a statistician working in drug development, I work at study level, project level and franchise level. I now work on clinical trials of three breast cancer drugs. I have been Hematology Franchise Biomarker Biostats Lead during 2013 - 2017 working closely with biomarker scientists to develop the biomarker strategy and leading some statistical analyses. I have also led project level safety reporting from 2012 to 2014 for one molecular, including first RMP (Risk Management Plan) and SCS (Summary of Clinical Safety) for regulatory filing.
Before I joined Roche, I have worked for five years in Academia, as Post-doc/Research Associate, Statistical Geneticist at Universities in Sweden and UK. My research focused on Bayesian Inference in Computation Biology.